Loading clinical trials...
Loading clinical trials...
The goal of this study is to use the HepQuant dual cholate clearance assay, which has been shown to measure liver function in people with known chronic liver conditions, to assess severity of Fontan-a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HepQuant, LLC
Collaborators
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT07450846 · Acute Respiratory Distress Syndrome, Right Heart Failure
NCT06932081 · Adult Congenital Heart Disease, Congenital Heart Disease, and more
NCT06324396 · Fontan Circulation
NCT07029230 · Congenital Heart Surgery, Congenital Heart Disease in Children, and more
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions